Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Prolacta CR for Treatment of Neonatal Hypoglycemia

NCT07217483 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT07217483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07217483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Prolacta CR for Treatment of Neonatal Hypoglycemia
Lead sponsor
Baylor Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 14, 2024
Completion date
December 31, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal hypoglycemia